MACROGENICS INC — Director's Dealing 2020

Feb 24, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2020-02-20

Reporting Person: Bonvini Ezio (Sr VP, Research & CSO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-20	Employee stock option (right to buy)	$11.5	A	100000	Acquired	2030-02-20	Common Stock (100000.0)	Direct

Footnotes

F1: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter.